title: Oleate salt formation and mesomorphic behavior in the propranolol/oleic acid binary system.
abstract: Thermal analysis of propranolol/oleic acid mixtures prepared by solvent evaporation enabled construction of the binary system phase diagram. This allowed both physical and chemical interactions to be identified, including complex formation at the equimolar composition. An incongruent melting complex with a characteristic reaction point was identified in excess oleic acid compositions, a common property of fatty acid/fatty acid salt binary systems. The equimolar complex was confirmed to be propranolol oleate using infrared spectroscopy. Wide-angle X-ray powder diffractometry demonstrated that propranolol oleate possessed long-range positional order ( approximately 25 A d spacing) accompanied by a degree of disorder over shorter d spacings. Such a pattern suggested mesophase formation, explaining the unctuous nature of propranolol oleate at room temperature. Accurate measurement of the long-range d spacing was achieved using small-angle X-ray scattering, permitting differentiation of the three different phases identified (phase I: 25.4 A, phase II: 24.6 A, phase III: 25.4-25.5 A). The implications of drug fatty acid salt formation and also mesomorphism in pharmaceutical systems are discussed.
authors.affiliation: Drug Delivery Group, Postgraduate Studies in Pharmaceutical Technology, The School of Pharmacy, University of Bradford, Bradford, BD7 1DP, UK.
authors.forename: K J
authors.initials: KJ
authors.lastname: Crowley
authors.forename: R T
authors.initials: RT
authors.lastname: Forbes
authors.forename: P
authors.initials: P
authors.lastname: York
authors.forename: H
authors.initials: H
authors.lastname: Nyqvist
authors.forename: O
authors.initials: O
authors.lastname: Camber
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D018360:Crystallography, X-Ray; D019301:Oleic Acid / Q000737:chemistry*; D010592:Pharmaceutic Aids / Q000737:chemistry*; D011433:Propranolol / Q000737:chemistry*; D012542:Scattering, Radiation; D012997:Solvents / Q000737:chemistry; D017550:Spectroscopy, Fourier Transform Infrared; D014965:X-Rays
chemical_list: D000319:Adrenergic beta-Antagonists; D010592:Pharmaceutic Aids; D012997:Solvents; D019301:Oleic Acid; D011433:Propranolol